On Oct. 29, 2021, the U.S. FDA authorized the Pfizer pediatric vaccine for children 5 to 11 years old under an Emergency Use Authorization (EUA), meaning the vaccine was proven safe and effective for this age group. This vaccine is a two-dose series, and the doses should be administered three weeks apart. Information about dosage and efficacy can be found in the vaccine’s U.S. FDA fact sheet.